Lymphocyte-to-monocyte ratio is a predictor of clinically significant prostate cancer at prostate biopsy. Cho MC, Yoo S, Choo MS, Son H, et al. Prostate 2021 Sep 13. doi: 10.1002/pros.24222.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Cho MC, Yoo S, Choo MS, Son H, et al. Lymphocyte-to-monocyte ratio is a predictor of clinically significant prostate cancer at prostate biopsy. Prostate 2021 Sep 13. doi: 10.1002/pros.24222.
PMID: 34516662